Bromide

Bromide

SCHEMBL2448830

C(=C[P+](c1ccccc1)(c1ccccc1)c1ccccc1)[P+](c1ccccc1)(c1ccccc1)c1ccccc1.[Br-].[Br-]

nearest known ligand 0.43

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACHECHKACHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNB1CHRNDCHRNECHRNGHRH2OPRM1

The experimentally established mechanism targets of Bromide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
HIF1A Q16665 1/20 0.43
ALDH1A1 P00352 6/20 0.37
TDP1 Q9NUW8 1/20 0.37
SNCA P37840 1/20 0.32
TSHR P16473 3/20 0.32
CYP1A2 P05177 1/20 0.32
CYP2D6 P10635 1/20 0.32
CYP2C19 P33261 1/20 0.32
DPP4 P27487 2/20 0.32
F2 P00734 1/20 0.32
MAOB P27338 1/20 0.32
CYP2A6 P11509 1/20 0.32
LMNA P02545 2/20 0.30
MAPK1 P28482 1/20 0.30
L3MBTL1 Q9Y468 1/20 0.30
MAPT P10636 1/20 0.30
HTT P42858 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Bromide SCHEMBL3963166 0.83 HIF1A (0.36) HIF1AALDH1A1TDP1TSHRMAOB
Bromide SCHEMBL17048069 0.81 MAOB (0.48) ALDH1A1CYP1A2CYP2D6MAOBLMNA
Bromide SCHEMBL2450382 0.79 ALDH1A1 (0.39) HIF1AALDH1A1TDP1TSHRCYP2C19
Bromide SCHEMBL7877084 0.79 TSHR (0.35) HIF1AALDH1A1TSHR
Bromide SCHEMBL7877086 0.79 TSHR (0.35) HIF1AALDH1A1TSHR
Hydrochloric Acid SCHEMBL29761216 0.77 HIF1A (0.36) HIF1AALDH1A1TDP1TSHRMAOB
Phosphine SCHEMBL28255509 0.77 ALDH1A1 (0.38) HIF1AALDH1A1TDP1TSHRMAPT
SCHEMBL35319498 0.75 ALDH1A1 (0.41) HIF1AALDH1A1TDP1TSHRCYP1A2
Hydrochloric Acid SCHEMBL28201563 0.75 MAOB (0.48) ALDH1A1CYP1A2CYP2D6MAOBLMNA
Bromide SCHEMBL8664990 0.74 HIF1A (0.39) HIF1AALDH1A1TSHRCYP1A2CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10928728-B2 Photoactivable nitrogen bases BASF SE (DE) 2021-02-23 US disclosed
US-20210033972-A1 PHOTOACTIVABLE NITROGEN BASES BASF SE (DE) 2021-02-04 US disclosed
US-20180217498-A1 PHOTOACTIVABLE NITROGEN BASES BASF SE (DE) 2018-08-02 US disclosed
US-9921477-B2 Photoactivable nitrogen bases BASE SE (DE) 2018-03-20 US disclosed
EP-2145231-B1 PHOTOACTIVABLE NITROGEN BASES BASF SE (DE) 2011-09-14 EP disclosed
US-20100105794-A1 PHOTOACTIVABLE NITROGEN BASES CIBA CORPORATION (US) 2010-04-29 US disclosed
EP-0970085-B1 PHOTOACTIVATABLE NITROGEN-CONTAINING BASES BASED ON ALPHA-AMINO ALKENES CIBA SC HOLDING AG (CH) 2002-07-24 EP disclosed
US-6087070-A AS PHOTOINITIATORS FOR BASE-CATALYZABLE REACTIONS CIBA SPECIALTY CHEMICALS CORPORATION (US) 2000-07-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210033972-A1 PHOTOACTIVABLE NITROGEN BASES CBR1, ARNT, NR0B1 HIF1A 1258/4885ALDH1A1 1659/4885TDP1 3557/4885
US-10928728-B2 Photoactivable nitrogen bases CBR1, NR0B1, NR0B2 HIF1A 1136/4885ALDH1A1 1733/4885TDP1 3593/4885
US-20180217498-A1 PHOTOACTIVABLE NITROGEN BASES CBR1, NR0B1, NR0B2 HIF1A 1136/4885ALDH1A1 1733/4885TDP1 3593/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.